4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%

MT Newswires Live
01/30

4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse filing.

The University of Chicago Medicine will become the fifth US academic medical center to adopt the CT:VQ product, per the filing.

The expanded arrangement includes a renewed imaging analysis platform agreement and a commercial contract, including an initial package of prepaid CT:VQ scans to boost clinical deployment.

4DMedical's shares jumped past 7% in recent Friday trade.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10